SeekingAlphaSeptember 22, 2026 at 11:00 AM NYLast Month
Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria - Slideshow
2026-09-22. The following slide deck was published by Celldex Therapeutics, Inc.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha
